Palbociclib (P) In Patients (Pts) With Non-Small Cell Lung Cancer (Nsclc) With Cdkn2a Alterations: Results From The Targeted Agent And Profiling Utilization Registry (Tapur) Study. Eugene R Ahn,Pam K. Mangat,Elizabeth Garrett-Mayer,Susan Halabi,Elie G. Dib,Daniel Ernest Haggstrom, Kathryn B. Alguire,Ricardo H. Alvarez,Carmen Julia Calfa,Timothy Lewis Cannon,Pamela A. Crilley,Anu G. Gaba,Alissa S. Marr,Ashish Sangal,Ramya Thota, Kaitlyn R. Antonelli, Samiha Islam, Andrew Lawrence Rygiel,Suanna S. Bruinooge,Richard L. SchilskyJOURNAL OF CLINICAL ONCOLOGY（2019）引用 27|浏览37暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
